查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529880

灌注系統市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2024-2030 年

Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

灌注系統市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球灌注系統市場預計將達到 15.5 億美元。

此外，預計2024年至2030年該市場將以4.8%的複合年成長率發展。慢性病盛行率增加、器官移植發生率增加和多重器官衰竭等因素預計將推動市場成長。此外，增加對細胞研究的投資和增加生技藥品製造預計將進一步推動灌注系統產業的成長。

在大流行的前半段，灌注系統的銷售量直線下降。世界各國政府實施的封鎖和限制導致去醫院就診的病患減少、手術減少、研發活動放緩。然而，隨著政府和醫療保健相關人員活性化遏制病毒傳播並為未來類似事件做好準備，預計市場可能會在 2021 年復甦並在預測期內達到高峰。

灌注系統市場報告亮點

  • 根據應用，灌注系統市場分為心肺灌注系統、細胞灌注系統和體外器官灌注系統。由於全球心臟疾病的高發生率，心肺灌注系統將在 2023 年佔據市場主導地位。
  • 按地區分類，2023年北美市場佔有率最高。慢性病盛行率的上升、醫療保健行業的成熟以及器官捐贈者數量的增加正在推動該地區的市場成長。
  • COVID-19 大流行對灌注系統市場產生了重大負面影響。醫療保健優先事項的變化、社交疏遠和全球封鎖等因素導致手術減少、器官捐贈和移植減少。
  • 冠狀病毒的爆發導致灌注系統的銷售量下降，但在第一波大流行過後，預計市場將在預測期內復甦並達到新冠病毒爆發前的成長水準。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章灌注系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 灌注系統市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 灌注系統市場：按應用估算和趨勢分析

  • 細分儀表板
  • 灌注系統市場：依應用進行變化分析
  • 按應用分列的灌注系統市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 心肺灌注系統
  • 細胞灌注系統
  • 體外器官灌注系統

第5章灌注系統市場：區域估計與趨勢分析

  • 區域儀表板
  • 灌注系統市場：區域變化分析
  • 灌注系統市場：按技術和最終用途的區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 2018-2030 年北美灌注系統市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲灌注系統市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區灌注系統市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲灌注系統市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲灌注系統市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 市場參與企業分類
  • 主要企業簡介
    • Getinge
    • Medtronic, plc
    • LivaNova PLC
    • Terumo Corporation
    • Nipro Corporation
    • Fresenius SE &Co. KGaA（XENIOS AG）
    • Repligen Corporation
    • Spectrum Medical
    • Merck KGaA
    • Harvard Bioscience, Inc.
    • Lifeline Scientific
    • ALA Scientific Instruments, Inc.
    • XVIVO Perfusion AB
Product Code: GVR-1-68038-470-3

Perfusion Systems Market Growth & Trends:

The global perfusion systems market size is projected to reach USD 1.55 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.8% from 2024 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Perfusion Systems Market Report Highlights:

  • Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2023 due to the high prevalence of cardiac diseases globally
  • In terms of region, North America accounted for the highest market share in 2023. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
  • The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
  • The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1 Segment Definitions
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Perfusion Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular and respiratory diseases
      • 3.2.1.2. Rising number of organ transplantations
      • 3.2.1.3. Growth in aging population and increasing incidence of multiple organ failures
      • 3.2.1.4. Government and NGO initiatives to encourage organ donation
      • 3.2.1.5. Increasing investments in cell-based research
      • 3.2.1.6. Rise in biologic manufacturing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of organ transplantation
      • 3.2.2.2. Ethical concerns and high cost of cell-based research
  • 3.3. Perfusion Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Perfusion systems Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Perfusion Systems Market: Application Movement Analysis
  • 4.3. Perfusion Systems Market by Application Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Cardiopulmonary Perfusion System
    • 4.5.1. Cardiopulmonary Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Oxygenators
      • 4.5.2.1. Oxygenators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Heart-Lung Machine
      • 4.5.3.1. Heart-Lung Machine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Perfusion Pumps
      • 4.5.4.1. Perfusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Cannula
      • 4.5.5.1. Cannula Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Monitoring System
      • 4.5.6.1. Monitoring System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Cell Perfusion System
    • 4.6.1. Cell Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Bioreactor Perfusion System
      • 4.6.2.1. Bioreactor Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Microfluidic Perfusion System
      • 4.6.3.1. Microfluidic Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Gravity/Pressure-driven Perfusion System
      • 4.6.4.1. Gravity/Pressure-driven Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Small Mammal Organ Perfusion System
      • 4.6.5.1. Small Mammal Organ Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Ex-Vivo Organ Perfusion System
    • 4.7.1. Ex-Vivo Organ Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Hypothermic
      • 4.7.2.1. Hypothermic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Normothermic
      • 4.7.3.1. Normothermic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Perfusion Systems Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Perfusion systems Market movement analysis
  • 5.3. Perfusion systems Market: Regional Estimates & Trend Analysis by Technology & End-use
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. North America
    • 5.5.1. North America Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. U.S. Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Canada Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement scenario
      • 5.5.4.5. Mexico Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. UK Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Germany Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. France Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Italy Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Reimbursement scenario
      • 5.6.6.5. Spain Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Denmark
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Reimbursement scenario
      • 5.6.7.5. Denmark Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Reimbursement scenario
      • 5.6.8.5. Sweden Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.9. Norway
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Competitive Scenario
      • 5.6.9.3. Regulatory Framework
      • 5.6.9.4. Reimbursement scenario
      • 5.6.9.5. Norway Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. Japan Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. China Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. India Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. South Korea Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Reimbursement scenario
      • 5.7.6.5. Australia Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory Framework
      • 5.7.7.4. Reimbursement scenario
      • 5.7.7.5. Thailand Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Reimbursement scenario
      • 5.8.2.5. Brazil Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Reimbursement scenario
      • 5.8.3.5. Argentina Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Middle East & Africa
    • 5.9.1. Middle East & Africa Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. Reimbursement scenario
      • 5.9.2.5. South Africa Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Reimbursement scenario
      • 5.9.3.5. Saudi Arabia Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. Reimbursement scenario
      • 5.9.4.5. UAE Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Reimbursement scenario
      • 5.9.5.5. Kuwait Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Getinge
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic, plc
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. LivaNova PLC
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Terumo Corporation
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Nipro Corporation
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Fresenius SE & Co. KGaA (XENIOS AG)
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Repligen Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Spectrum Medical
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Merck KGaA
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Harvard Bioscience, Inc.
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Lifeline Scientific
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. ALA Scientific Instruments, Inc.
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. XVIVO Perfusion AB
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Perfusion systems market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America Perfusion systems market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 8 Mexico Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe Perfusion systems market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 11 Germany Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 13 France Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 14 Italy Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 15 Spain Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 16 Denmark Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 17 Sweden Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 18 Norway Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Perfusion systems market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 21 China Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 23 India Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 24 South Korea Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 25 Australia Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 26 Thailand Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America Perfusion systems market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 31 MEA Perfusion systems market, by country, 2018 - 2030 (USD Million)
  • Table 32 MEA Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 33 South Africa Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 35 UAE Perfusion systems market, by application, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Perfusion systems market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Perfusion systems market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Perfusion systems market, application outlook key takeaways (USD Million)
  • Fig. 12 Perfusion systems market application movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Cardiopulmonary Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Oxygenators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Heart-Lung Machine market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Perfusion Pumps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Cannula market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Monitoring System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cell Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Bioreactor Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microfluidic Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Gravity/Pressure-driven Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Small Mammal Organ Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ex-Vivo Organ Perfusion System market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Hypothermic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Normothermic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Perfusion systems market: Regional key takeaways (USD Million)
  • Fig. 29 Perfusion systems market regional outlook, 2023 & 2030, USD Million
  • Fig. 30 North America Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Norway Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Perfusion systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 List of key emerging company's/technology disruptors/innovators